Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease

This publication has 20 references indexed in Scilit:

• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
  The Pediatric Infectious Disease Journal, 2002
• Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
  The Pediatric Infectious Disease Journal, 2001
• Rethinking Recommendations for Use of Pneumococcal Vaccines in Adults
  Clinical Infectious Diseases, 2001
• Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspA
  The Journal of Infectious Diseases, 2000
• Diversity of PspA: Mosaic Genes and Evidence for Past Recombination in Streptococcus pneumoniae
  Infection and Immunity, 2000
• Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
  Vaccine, 2000
• Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I
  Clinical Infectious Diseases, 2000
• Reduction in Functional Antibody Activity Against Streptococcus pneumoniae in Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody Avidity
  Clinical Infectious Diseases, 1999
• Magnitude, Duration, Quality, and Function of Pneumococcal Vaccine Responses in Elderly Adults
  The Journal of Infectious Diseases, 1998
• Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
  The Journal of Experimental Medicine, 1987